| Financial Year |
March 31 2023 |
| Monetary Funds |
727,654,200.05 |
| Held-for-trading Financial Assets |
235,644,609.64 |
| Notes Receivable |
28,398,256.32 |
| Accounts Receivable |
1,504,866,175.10 |
| Advances to Suppliers |
61,054,459.07 |
| Other Receivables |
62,446,728.31 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
262,364,291.86 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
8,540,012.36 |
| Other Current Assets |
78,427,932.13 |
| Total Current Assets |
3,627,981,235.48 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
9,872,313.52 |
| Investment Properties |
40,511,101.52 |
| Fixed Assetes |
262,911,871.28 |
| Under-construction Projects |
418,921,643.93 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
139,676,168.18 |
| R&D expenses |
-- |
| Goodwill |
543,945.48 |
| Long-Term Deferred and Prepaid Expenses |
49,954,322.45 |
| Deferred Income Tax Assets |
92,682,836.03 |
| Other Non-Current Assets |
2,820,623,238.07 |
| Sub-Total of Non-Current Assets |
3,875,019,498.87 |
| Total Assets |
7,503,000,734.35 |
| Short-Term Loans |
483,054,877.46 |
| Trading Financial liabilities |
-- |
| Notes Payable |
123,339,859.02 |
| Accounts Payable |
1,181,611,645.61 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
26,250,683.69 |
| Taxes Payable |
12,601,832.17 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
150,065,126.01 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
102,312,042.56 |
| Other Current Liabilities |
191,944,804.02 |
| Sub-Total of Current Liabilities |
2,498,973,392.64 |
| Long-term Loans |
1,465,476,677.89 |
| Bonds Payable |
588,085,292.21 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
2,846,714.65 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,085,287,123.96 |
| Total Liabilities |
4,584,260,516.60 |
| Paid-In Capital(Or Share Stock) |
409,735,512.00 |
| Capital Surplus |
552,592,507.63 |
| Surplus Reserve |
212,762,693.20 |
| LESS:Treasury Stock |
33,979,848.00 |
| Undistributed Profits |
1,616,740,843.68 |
| Minority Stockholder's Interest |
41,654,391.06 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,877,085,826.69 |
| Owner's Equity（Stockholder's Equity） |
2,918,740,217.75 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,503,000,734.35 |
